Catalyst Pharmaceuticals, Inc. Share Price & Technical Analysis
CPRX · $31.26 (-0.06%)
Healthcare / Biotechnology
$31.26
-0.06%
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-meth…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
11% return in May, -6% avg return in past 3 year May month.
34% return in 2026, 12% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 4% | -5% | 10% | 12% | 11% | – | – | – | – | – | – | – | 34% |
| 25 | 7% | 3% | 6% | 0% | 3% | -13% | -2% | -2% | -4% | 4% | 10% | 1% | 12% |
| 24 | -14% | 10% | -2% | -4% | 7% | -5% | 11% | 17% | -1% | 10% | 1% | -5% | 25% |
| 23 | -17% | -2% | 7% | -5% | -27% | 18% | 2% | 1% | -17% | 6% | 16% | 16% | -2% |
| 22 | -15% | 34% | 6% | -8% | -5% | -3% | 46% | 32% | -5% | 6% | 20% | 10% | 119% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Strong
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$3.81B
P/E ratio
18.54
52W high
$32.56
52W low
$19.05
Volume
19,93,234
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Catalyst Pharmaceuticals, Inc. share price today?
- Catalyst Pharmaceuticals, Inc. (CPRX) last traded around $31.26 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CPRX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CPRX. Download the app for real-time alerts.
- How can I analyze Catalyst Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.